Patent details

Basic Information

Publication number:

EP2515941

PCT Application Number:

US2010061347

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107982365

PCT Publication Number:

WO2011084750

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL FORMULATION OF BEVACIZUMAB

French Title of Invention:

FORME PHARMACEUTIQUE DU BÉVACIZUMAB

German Title of Invention:

PHARMAZEUTISCHE FORMULIERUNG MIT BEVACIZUMAB

SPC Number:

Dates

Filing date:

20/12/2010

Grant date:

13/11/2019

EP Publication Date:

31/10/2012

PCT Publication Date:

14/07/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/11/2019

EP B1 Publication Date:

13/11/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/12/2019

Expiration date:

20/12/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/11/2019

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

LI, Megan

Address:

United States (US)

2

Name:

KAMERZELL, Timothy, J.

Address:

United States (US)

3

Name:

LIU, Hong

Address:

United States (US)

4

Name:

CROMWELL, Mary

Address:

United States (US)

5

Name:

GOKARN, Yatin, R.

Address:

United States (US)

Priority

Priority Number:

288535 P

Priority Date:

21/12/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 39/395; A61K 47/26; A61K 47/18;

Publication

European Patent Bulletin

Issue number:

201946

Publication date:

13/11/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages